VALacyclovir In Delaying Antiretroviral Treatment Entry.
Phase of Trial: Phase III
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Valaciclovir (Primary)
- Indications Herpes simplex virus type 2 infections; HIV infections; HIV-1 infections
- Focus Biomarker; Therapeutic Use
- Acronyms VALIDATE
- 02 Mar 2018 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 02 Jun 2017 Planned End Date changed from 1 Sep 2017 to 1 Aug 2017.